Łomiak M, Gajek Z, Stępnicki J, Lembas A, Mikuła T, Wiercińska-Drapało A. Lipid profile after switching from a TDF (tenofovir disoproxil)-containing to TAF (tenofovir alafenamide)-containing regimen in virologically suppressed people living with HIV. JMS [Internet]. 2023 Sep. 26 [cited 2024 Jul. 3];92(4):e808. Available from: https://jms.ump.edu.pl/index.php/JMS/article/view/808